Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Altoona, PA MSA — September 2026
Altoona's tight labor market can't supply the talent Life Sci needs.
Altoona's 3.7% unemployment rate reflects a tight but shallow labor pool, forcing Life Sci employers to compete on national terms where CRA pay runs $10,000 higher than the metro median.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Altoona unemployment rate: 3.7% — July 2026, vs 4.1% PA and US rates
- CRA advertised pay gap: $80,883 vs $90,956 — Metro median vs national median, both rising
- PA average weekly wage: -0.8% YoY — June 2026, despite statewide 4.1% unemployment
- Altoona manufacturing employment: 7,400 jobs — Flat month-over-month, July 2026
Key takeaways
CRA pay gap signals a mobility premium, not a local shortage.
Metro CRA advertised pay sits roughly 11% below the national median, yet both are rising significantly — a pattern consistent with employers importing talent rather than competing purely on local wage levels. Compensation plans anchored to Altoona-only data risk underpricing roles that actually compete nationally.
Flat manufacturing employment masks a quality and compliance talent gap.
Manufacturing headcount held steady at 7,400 jobs month-over-month, but statewide signals show cell/gene and biologics manufacturing talent remains the scarcest specialty, with Director CMC roles commanding $220K-$520K elsewhere in Pennsylvania. Flat local headcount likely reflects limited specialized capacity rather than satisfied demand.
Pennsylvania's wage stagnation weakens candidates' negotiating leverage statewide.
Statewide average weekly wages fell 0.8% year-over-year even as unemployment held near historic lows, suggesting reduced quit rates and softer wage pressure broadly. For Altoona-based Life Sci employers, this may create a window to recruit experienced talent from larger Pennsylvania life sciences hubs at less aggressive premiums than seen in 2024-2025.
Build-vs-outsource math tilts further toward CDMOs for specialized functions.
Minaris's new Philadelphia-based AAV manufacturing partnership with Asimov underscores that in-state CDMO capability for complex modalities keeps expanding, while Altoona's labor base offers no comparable specialized bench. Organizations headquartered or operating in this metro may find outsourcing increasingly favorable for any function requiring cell/gene or advanced biologics expertise.
Median advertised pay by role — Altoona, PA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $89,211 | $124,624 | $141,205 | Significant increase | $131,354 |
| Clinical Research Associate * | $61,167 | $80,883 | $100,914 | Significant increase | $90,956 |
| Lab Technician * | $39,619 | $46,681 | $52,287 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $66,798 | $95,346 | $112,818 | Stable | $104,000 |
| Clinical Data Manager * | $97,693 | $142,800 | $164,232 | Moderate increase | $123,031 |
| Biostatistician * | $107,580 | $139,109 | $159,860 | Moderate increase | $133,322 |
| Validation Engineer * | $89,151 | $106,202 | $113,415 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Altoona's labor market held tight at 3.7% unemployment in July 2026 against a 57,800-person labor force, with total nonfarm employment edging down to 62,100 as manufacturing stayed flat at 7,400 jobs and healthcare continued anchoring regional demand. Low local unemployment combined with a historically thin candidate pool for credentialed scientific and regulatory roles means any Life Sci employer hiring into this metro is effectively drawing from a national — not local — talent pool.
What it means
Altoona's small, services-heavy labor base cannot supply specialized R&D, quality, or regulatory talent locally, so headcount decisions here function less like metro hiring and more like remote or relocation-dependent recruiting against national compensation benchmarks, including the Clinical Research Associate national median of $90,956 running well above the metro's $80,883. That gap signals local employers may need to pay above metro norms to compete for mobile scientific talent, or lean harder on CRO/CDMO partners who already operate at regional scale. Consider evaluating whether specialized roles in this metro are better filled through outsourcing arrangements than through direct local hiring, given how thin the credentialed labor pool remains.
Looking ahead
Worth watching: Altoona's nonfarm employment dipped 100 jobs month-over-month into July; watch whether this is noise or the start of a softening trend that could ease pressure on administrative and support hiring for Life Sci operations based in the metro.
Emerging pressure point: Statewide biotech/pharma hiring from GSK (40+ roles) and Insmed (60+ roles) in Greater Philadelphia could pull regional talent away from smaller, outlying markets like Altoona, intensifying competition for any mobile scientific or regulatory candidates willing to relocate.
Potential inflection point: National CRA pay is rising significantly year-over-year while Pennsylvania's broader wage growth stays muted — a divergence that, if sustained, could widen the premium Altoona-based employers must pay to retain clinical research talent against better-resourced metros.
Early indicator: September's national wave of biopharma layoffs (BioMarin, Bristol Myers) paired with 64% of biopharma organizations still actively recruiting suggests displaced specialized talent may enter regional candidate pools; monitor whether any of that movement reaches Pennsylvania outside Philadelphia.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.